Imagine a group of murderers, terrorizing the world under the guise of protecting our safety. After thousands of unnecessary deaths, someone finally stands up to the killers and sends all but one to jail. Why leave this one free? Certain people claim he’s less dangerous than his associates. He really[…]
Asbestos & Mesothelioma Studies
New research suggests earlier mesothelioma diagnosis is a possibility
Those familiar with the asbestos-caused cancer mesothelioma are well aware the disease takes decades to develop and by the time it’s recognized, it’s too late for recovery. When symptoms finally develop and mesothelioma is diagnosed, its victims often survive less than one year. In 2008, Japanese researchers released a study[…]
New study suggests breast cancer drug may shrink mesothelioma tumors
After new evidence surfaced suggesting the enzyme aromatase is associated with malignant mesothelioma, Italian scientists began testing breast cancer drug Aromasin (exemestane) on mice and mesothelioma cells. Designed to inhibit aromatase, Aromasin curbs cell growth in breast cancer patients by helping reduce the amount of estrogen in the body. In[…]
Alimta remains best treatment for victims of malignant pleural mesothelioma
For those with inoperable malignant pleural mesothelioma, Alimta (permetrexed) combined with cisplatin remains the top treatment. Japanese researchers recently analyzed the results of 30 patients taking either Gemzar or the Alimta combination and compared complications, disease control and survival rates. Thirty mesothelioma cases were examined featuring 13 patients taking Gemzar[…]
New treatment may inhibit the growth of mesothelioma cells
A recent study suggests CARP-1 Functional Mimetics (CFMs) initiated mesothelioma cell death while prohibiting their migration into new colonies. The concept is to mimic the Cell Cycle and Regulatory Protein (CARP) 1 with its ability to assist with apoptosis, or programmed cell death. When new cells become too abundant and[…]
